About this trial
Cancer is a leading cause of death and will affect many people in their lifetimes. Organizations such as the American Cancer Society and the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) have noted that dietary quality is a key factor influencing cancer risk, but most Americans do not meet these dietary guidelines for cancer prevention. The proposed study will enroll adults from the community (n=236 index participants, 236 household members; N = 472) who have low adherence to WCRF/AICR's four dietary guidelines. Participants will be randomized to either nutrition education or the Eatwell intervention. The Eatwell intervention content is focused on helping participants make healthier grocery shopping decisions, eat at home more often to take advantage of the optimal defaults present there, and learn how to navigate temptation when eating away from home. The findings will be relevant not only to the field of cancer prevention, but to the prevention of other diseases for which dietary quality is important.
Eligibility criteria
Qualifiers
Age 18 or older
Access to technology necessary to receive emails and join videoconferencing meetings
Ability to read and speak English
Willingness to be randomized to either study condition, including ability and willingness to attend intervention sessions
Disqualifiers
A medical or psychiatric condition, including self-reported history of anorexia nervosa or bulimia nervosa, that may limit appropriateness of or ability to comply with dietary recommendations
A psychiatric condition, including self-reported history of anorexia nervosa or bulimia nervosa, that may make it difficult or inappropriate for household member to serve in support role
Currently taking medication that can substantively change appetite or eating behavior, including using of a GLP-1 medication
Planning to enroll in another lifestyle modification program in the next 18 months
Trial design
Treatments tested in this trial
- Eatwell
- Nutrition Education Control Group
Treatment groups
Sponsors and collaborators
Drexel University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator